Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Skin Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Not applicableNot Yet RecruitingNCT06553781
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma

Who this might be right for
Malignant Melanoma
Fudan University 28
Early research (Phase 1)Looking for participantsNCT07190469
What this trial is testing

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer
ProteinQure Inc. 80
Early research (Phase 1)Study completedNCT02583269
What this trial is testing

Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmUnresectable Malignant Neoplasm
Wake Forest University Health Sciences 24
Testing effectiveness (Phase 2)Study completedNCT02614794
What this trial is testing

Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Seagen Inc. 612
Testing effectiveness (Phase 2)Temporarily pausedNCT05756556
What this trial is testing

T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

Who this might be right for
MelanomaMalignant Melanoma
ImmVira Pharma Co. Ltd 68
Testing effectiveness (Phase 2)Study completedNCT03108131
What this trial is testing

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

Who this might be right for
Skin Squamous Cell CarcinomaAppendix AdenocarcinomaRare Lesion+9 more
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Early research (Phase 1)Ended earlyNCT02327390
What this trial is testing

Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma

Who this might be right for
Stage IIIC Skin MelanomaStage IV Melanoma
Case Comprehensive Cancer Center 3
Early research (Phase 1)Ended earlyNCT01212276
What this trial is testing

A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaMalignant Metastatic MelanomaAdvanced Melanoma+1 more
Morphotek 18
Early research (Phase 1)Looking for participantsNCT06171750
What this trial is testing

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more
Ankyra Therapeutics, Inc 97
Large-scale testing (Phase 3)Study completedNCT01689519
What this trial is testing

A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 495
Early research (Phase 1)Study completedNCT02571036
What this trial is testing

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Who this might be right for
Gastrointestinal Stromal TumorsAdvanced Systemic MastocytosisAdvanced Cancers
Deciphera Pharmaceuticals, LLC 282
Testing effectiveness (Phase 2)Looking for participantsNCT06090266
What this trial is testing

OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+4 more
OncoResponse, Inc. 168
Not applicableLooking for participantsNCT06413212
What this trial is testing

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Who this might be right for
Lung CancerBreast CancerGastric Cancer+1 more
Liu Huang 55
Early research (Phase 1)Active Not RecruitingNCT04387084
What this trial is testing

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

Who this might be right for
Advanced Malignant Skin NeoplasmMetastatic Malignant Skin Neoplasm
University of Southern California 10
Early research (Phase 1)Ended earlyNCT01557114
What this trial is testing

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 19
Testing effectiveness (Phase 2)Study completedNCT02816021
What this trial is testing

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma
M.D. Anderson Cancer Center 24
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Next Page